In summary, while the use of GnRH agonist alone as the trigger agent showed comparable pregnancy rates and may mitigate the risk of OHSS, it is important to consider the lower oocyte retrieval rate and potential overload in medium cost and procedure time associated with this approach. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.